BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17669141)

  • 1. Urological malignancy after renal transplantation.
    Besarani D; Cranston D
    BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
    Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
    Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No increase of melanoma after kidney transplantation in the northern part of The Netherlands.
    Bastiaannet E; Homan-van der Heide JJ; Ploeg RJ; Hoekstra HJ
    Melanoma Res; 2007 Dec; 17(6):349-53. PubMed ID: 17992116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence and survival in kidney transplant patients.
    Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
    Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial cancer in patients with Endemic Balkan Nephropathy (EN) after renal transplantation.
    Zivcić-Cosić S; Grzetić M; Valencić M; Oguić R; Maricić A; Dordević G; Balen S; Orlić L; Racki S; Fuckar Z
    Ren Fail; 2007; 29(7):861-5. PubMed ID: 17994456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy after renal transplantation.
    Zeier M; Hartschuh W; Wiesel M; Lehnert T; Ritz E
    Am J Kidney Dis; 2002 Jan; 39(1):E5. PubMed ID: 11774131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess risk of cancer in renal transplant patients.
    Kessler M; Jay N; Molle R; Guillemin F
    Transpl Int; 2006 Nov; 19(11):908-14. PubMed ID: 17018126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urological de novo malignancy after kidney transplantation: a case for the urologist.
    Melchior S; Franzaring L; Shardan A; Schwenke C; Plümpe A; Schnell R; Dreikorn K
    J Urol; 2011 Feb; 185(2):428-32. PubMed ID: 21167532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.